Patents by Inventor Bronner Gunter

Bronner Gunter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
    Publication number: 20060248601
    Abstract: The invention discloses polypeptides (Unc-51 kinase, ROMA1, and/or 2TM protein) affecting the activity of Uncoupling Proteins (UCPs), thereby leading to an altered mitochondrial activity and thus contributing to membrane stability and/or function of organelles, preferably mitochondria. This invention relates to the use of these polypepetides in the diagnosis, study, prevention, and treatment of diseases and disorders, for example, but not limited to, metabolic diseases such as obesity, adipositas, eating disorders, wasting syndromes (cachexia), pancreatic dysfunctions (for example diabetes), disorders related to ROS production, and others.
    Type: Application
    Filed: March 27, 2002
    Publication date: November 2, 2006
    Inventors: Arnd Steuernagel, Bronner Gunter, Ciossek Thomas
  • Proteins involved in the regulation of energy homeostasis
    Publication number: 20050233956
    Abstract: The present invention discloses novel uses for energy homeostasis regulating proteins and polynucleotides encoding these in the diagnosis, study, prevention, and treatment of metabolic diseases and disorders.
    Type: Application
    Filed: May 2, 2003
    Publication date: October 20, 2005
    Applicant: DeveloGen Aktiengesellschaft Fur Entwicklungsbiologische Forschung
    Inventors: Karsten Eulenberg, Steuernagel Arnd, Hader Thomas, Meise Martin, Bronner Gunter
  • Cg3842 homologous proteins involved in the regulation of energy homeostasis
    Publication number: 20050107317
    Abstract: The present invention discloses CG3842 or SCAD homologous proteins regulating the energy homeostasis and the metabolism of triglycerides, and polynucleotides, which identify and encode the proteins disclosed in this invention. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of metabolic diseases and disorders.
    Type: Application
    Filed: March 7, 2003
    Publication date: May 19, 2005
    Inventors: Marcus Geese, Martin Meise, Bronner Gunter